The global contraceptives market is growing significantly due to increasing incidences of unwanted pregnancies, increasing prevalence of sexually transmitted diseases and advances in contraception techniques. In addition, government and non-government organizations are funding and supporting programs to encourage contraception. Large unexplored contraceptives market in emerging economies is creating ample opportunities for the global contraceptives market to grow at a considerable rate in the coming years. Several major players in the contraception market are actively involved in the research and new product development for contraception, which could meet the demand of cost effective long term contraception.

Explore Report at: https://www.psmarketresearch.com/market-analysis/contraceptives-market

The global contraceptives market is categorized as devices and drugs. Based on devices, the contraceptives market is categorized as contraceptive sponges, vaginal rings, contraceptive diaphragms, intrauterine devices (IUDs), subdermal implants, male condoms, female condoms, and others. The IUDs segment is further categorized as hormonal IUDs and copper IUDs. On the basis of drugs, the contraceptive market can be categorized as topical contraceptives, contraceptive injectable, and contraceptive pills. Contraceptive pills lead the global contraceptive drugs market due to its convenience in use and high efficiency in emergency contraception.

Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/contraceptives-market/toc-sample

Some of the major players operating in the global Contraceptives market are CooperSurgical Inc., Mayer Laboratories Inc., Merck & Co. Inc., Bayer AG, Actavis Inc., Reckitt Benckiser plc, Pfizer Inc., The Female Health Company, Teva Pharmaceutical Industries Ltd.